Sign Up to like & get
recommendations!
1
Published in 2018 at "Translational lung cancer research"
DOI: 10.21037/tlcr.2018.09.01
Abstract: The benefit from adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC) is modest with an overall survival (OS) benefit of only ~5% demonstrated in the Lung Adjuvant Cisplatin Evaluation (LACE) meta-analysis (1).
read more here.
Keywords:
bootstraps hunt;
nsclc;
hunt prognostic;
prognostic predictive ... See more keywords